Start-up company begins testing Alzheimer’s drug

Mithridion, a drug development company, co-founded by Jeff Johnson, professor in the Pharmaceutical Sciences Division, began a Phase 1 clinical trial of MCD-386, a small-molecule compound designed to treat Alzheimer’s patients. As highlighted in the …

Professor Kwon named to editorial board

Glen Kwon, professor in the Pharmaceutical Sciences Division, was named a member of the editorial board of the Biopharmaceutics & Drug Disposition Journal. This journal focuses on biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those …

New business aimed at drug delivery

A start-up drug delivery company using technologies developed by three UW-Madison professors–pharmacy professors Sandro Mecozzi and Glen Kwon, and anesthesiology Professor Robert Pearce–as well as chemistry graduate student Jonathan Fast was featured in the May …

Research may help you breathe easier

The research work of Ron Sorkness, professor in the Pharmacy Practice Division, and colleagues from the Severe Asthma Research Program (SARP) has identified key physiological differences between severe and non-severe forms of the disease. The …

Flu shot may leave heart patients at risk

Orly Vardney, assistant professor (CHS) and lead investigator in the research study on influenza vaccine responses in heart failure patients, presented research findings at the American College of Cardiology meeting in Chicago in March. The …

Editorial appointments recognize research

Mel de Villiers, associate professor in the Pharmaceutical Sciences Division, has been selected to serve on the Editorial Board of Current Drug Discovery Technologies. He was also recently appointed as an Associate Editor for the …

Early detection can be key

Eva Vivian, associate professor in the Pharmacy Practice Division, and School of Pharmacy students raised awareness for youth diabetes by providing screenings for the first time at the annual Multicultural Health Fair as highlighted in …